Abstract
Conclusions
1. Cevitamic acid, properly buffered, may be administered intramuscularly without discomfort or damage to tissue. 2. Studies of the urinary excretion and the blood content of vitamin C following the administration of cevitamic acid intramuscularly demonstrated that it is used by the body when administered by this route. 3. The height of increase in the blood level following the intramuscular injection of cevitamic acid is reached more slowly and is maintained for a longer time than after intravenous injections. 4. In cases of vitamin C deficiency, where cevitamic acid is improperly absorbed through the gastro-intestinal tract, or where the intravenous mode of administration is not feasible, the intramuscular route may be used.
Get full access to this article
View all access options for this article.